Metabolic Medicine Summit 2026
|
view program
Discover the highlights of the event
connect with us
Get your questions answered by our team
become a partner
Join as a sponsor and reserve your booth
Meet Our Featured Speakers
Sansei Fowler
CVS Health
Namrita Negi
Deloitte
Sansei Fowler
CVS Health
Steve Winshel
FULLFILL
THE FORUM FOR METABOLIC MEDICINE AND TREATMENT DEVELOPMENT
Welcome to the Metabolic Medicine Summit 2026, an event that brings together industry leaders and healthcare innovators committed to advancing metabolic therapies, technologies, and clinical strategies that are shaping the future of metabolic health.
Metabolic medicine faces significant challenges in turning advancements in gene editing, biomarkers, and precision therapies into meaningful clinical outcomes. This summit will highlight innovative approaches that aim to improve patient care and treatment.
Join us to gain practical insights, connect with global leaders, and help shape the future of metabolic health through innovation and collaboration.
key topics for
Emerging trends in metabolic therapies and patient-centered care
Innovative precision therapies targeting individual metabolic needs, along with patient-centered care models, are transforming treatment strategies worldwide.
Advancing biomarker-based research to enhance clinical outcomes
Biomarker research supports precise, effective treatments by identifying disease-specific markers that enhance outcomes and personalize care.
Case studies and clinical trials on therapies for metabolic disorders
Clinical trial data and case studies demonstrate the safety, effectiveness, and real-world impact of emerging therapies for metabolic disorders.
Breakthrough in therapeutic approaches for obesity and metabolic disorders
Advanced therapies for obesity and related metabolic dysfunctions using emerging drug platforms to improve health outcomes.
Innovations in biosimilars and peptide drugs for advanced treatments
Biosimilars and peptides provide cost-effective alternatives, as well as innovative therapies, for managing complex metabolic disorders.
Shaping metabolic medicine with global compliance and regulatory standards
New guidelines ensure the safety, effectiveness, and quality of metabolic therapies, aligning treatment practices with global standards to improve patient care and outcomes.
INDUSTRY TOPICS
NETWORKING EVENTS
LEADING EXPERTS
Q&A SESSIONS
Latest News
PARTNERSHIPS
10 Feb 2026
AstraZeneca Bets on AI to Rethink Obesity CareMARKET TRENDS
5 Feb 2026
Patients Take the Lead in US Metabolic Drug PricingPARTNERSHIPS
3 Feb 2026
AstraZeneca Brings AI In-House to Speed Drug DiscoveryRESEARCH
30 Jan 2026
New Metabolic Data Reignite Interest in Liver-Targeted Lipid Drugs
Roche’s 89bio Deal Heats Up the Race for MASH Drugs
PARTNERSHIPS
20 Jan 2026
Roche’s acquisition of 89bio signals rising confidence in late-stage MASH drugs and sharpens competition for metabolic liver disease treatments
they've attended our events
Expert Speakers
Vanessa Navarro
Danaher Corporation
Arjun Channi
Sanofi
Gulen Tonga
Tessera Therapeutics
Past Attendees
Danaher Corporation
Sanofi
Becton Dickinson
Tessera Therapeutics
Charles River
Inovio
Seran BioScience
Körber
Chiesi USA, Inc.
